|
| |
SCIENTIFIC PROGRAM
| SUNDAY, MARCH 11, 2001 |
| 08:00-10:00
|
ENDOTHELIAL CELL AND ANTI-ENDOTHELIAL CELL
ANTIBODY
Chairpersons:
P. Youinou, Brest Cedex, France
P.L. Meroni, Milano, Italy |
| 08:00 |
PATHOGENIC MECHANISMS OF
ANTI-ENDOTHELIAL CELL ANTIBODY
P. Youinou, Brest Cedex, France |
| 08:30 |
PROTECTIVE EFFECT OF CHOLESTEROL
LOWERING AGENTS ON ENDOTHELIAL CELL ACTIVATION
P.L. Meroni, Milano, Italy |
| 09:00 |
IMMUNOGLOBULINS G INHIBIT ENDOTHELIAL
ACTIVATION INDUCED BY ATHEROGENIC STIMULI
N. Ronda, R. Giacosa, R. Gatti, G. Orlandini, F. Bernini, C. Buzio, Parma,
Italy |
| 09:10 |
CD40 LIGAND ENHANCES PROSTAGLANDIN E2
AND THROMBOXANE A2 BY STIMULATING CYCLOOXYGENASE-2 IN ENDOTHELIAL CELLS
C.D. Garlichs, A. Schmeisser, T. Geis, G. Goppelt-Strube, S. Eskafi, J.
Ludwig, W. Daniel, Erlangen, Germany |
| 09:20 |
DIFFERENT PATHWAYS OF T CELL ACTIVATION
INDUCE DIFFERENTIAL FUNCTIONAL PROPERTIES OF T CELLS IN TERMS OF
ENDOTHELIAL CELL ACTIVATING CAPACITY: A NOVEL MECHANISM IN ATHEROGENESIS
C. Monaco, S. Young, M. Feldmann, E. Paleolog, London, UK |
| 09:30 |
ANTIENDOTHELIAL CELL ANTIBODIES AND
CORONARY ARTERY DISEASE
P.G. Vlachoyiannopoulos, M.G. Tektonidou, G. Anastasiadis, M. Kriakidis,
P. Youinou, A.M. Moutsopoulos, Athens, Greece, France |
| 09:40 |
ATHEROSCLEROSIS IN PATIENTS WITH
SYSTEMIC VASCULITIDES
V. Stvrtinova,
J. Rovensky, A. Tuchynova, Piestany, Slovak Republic |
| 10:00 |
Coffee Break |
| 10:30-13:20
|
ATHEROSCLEROSIS AND OTHER AUTOIMMUNE DISEASES
Chairpersons:
O. Vaarala, Helsinki, Finland
G.R.V. Hughes, London, UK
M. Maislos, Israel |
| 10:30 |
INTRODUCTION
G. Hughes, London, UK |
| 10:40 |
SLE AS A MODEL OF AUTOIMMUNE
ATHEROSCLEROSIS
O. Vaarala, Helsinki, Finland |
| 11:10 |
ANTI-PHOSPHOLIPID SYNDROME
(HUGHES
SYNDROME) AND ATHEROSCLEROSIS
M.A. Khamashta, O. Amengual, T. Atsumi, G. Hughes, London, UK |
| 11:40 |
CERAMIDE MEDIATED APOPTOSIS IN
ATHEROSCLEROSIS
T. Goldkorn, Davis, CA, USA |
| 12:00 |
ENDOTHELIAL DYSFUNCTION IN
1° VASCULITIS
- A MODEL FOR ATHEROSCLEROSIS?
P.A. Bacon, K. Raza, A. Filer, D. Carruthers, J. Gardner-Medwin, J.
Townend, Birmingham, UK
|
| 12:10 |
PARAOXONASE ACTIVITY IS DRAMATICALLY
DECREASED IN PATIENTS POSITIVE FOR ANTICARDIOLIPIN ANTIBODIES
M. Lambert, A. Bouillier, P. Duriez, V. Queyrel, U. Michon-Pasturel, M.
Hebbar, E. Hachulla, J-C. Fruchart, P-Y. Hatron, B. Devulder, Lille,
France |
| 12:20 |
AUTO-IMMUNITY IN PATIENTS WITH PREMATURE
ATHEROSCLEROSIS; THE ROLE OF ANTI NEUTROPHIL CYTOPLASMATIC ANTIBODIES
(ANCA)
P.L. Van Haelst, F.W. Asselbergs, J.J. Van Doormaal, J.F. May, R. Gans,
J.W. Cohen Tervaert, Groningen, The Netherlands |
| 12:30 |
ANTICARDIOLIPIN ANTIBODIES AS A RISK
FACTOR FOR ATHEROSCLEROSIS IN PATIENTS WITH AUTO-IMMUNE DISEASES.
P.G. Vlachoyiannopoulos, P. Kanellopoulos, R. Mastorakou, A. Tektonidou,
H. Moutsopoulos, Athens, Greece |
| 12:40 |
A PRELIMINARY STUDY OF THE
E-SELECTIN
A561C POLYMORPHISM, A CANDIDATE GENETIC RISK FACTOR FOR ATHEROSCLEROSIS,
IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
I.N. Bruce, M. El-Magadmi, A. Ansari, L. Teh, A.H. Hajeer, Manchester, UK
|
| 12:50 |
ANTICARDIOLIPIN ANTIBODIES FROM PATIENTS
WITH THE ANTIPHOSPHOLIPID ANTIBODY SYNDROME RECOGNIZE EPITOPES IN BOTH b2GP1 AND OXIDIZED LOW-DENSITY LIPOPROTEIN
S. Horko, P.P. Chen, D.W. Branch, W. Palinski, J. Witztum, San Diego, CA,
USA |
| 13:00 |
REDUCED PROLIFERATION AND MORPHOLOGICAL
ALTERATIONS OF ENDOTHELIAL CELLS (ECS) CULTURED IN THE PRESENCE OF SERA
FROM PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME
P.G. Vlachoyiannopoulos, C. Petrovas, C. Murphy, T. Fotsis, H.
Moutsopoulos, Athens, Greece |
| 13:10 |
CLOSING REMARKS
D. Harats, Tel Hashomer, Israel
Y. Shoenfeld, Tel Hashomer, Israel
G. Wick, Innsbruck, Innsbruck, Austria |
|
